Review
doi: 10.1016/s0149-7634(88)80061-7.
A role for biogenic amines in developmental language disorders
Affiliations
- PMID: 3067156
- DOI: 10.1016/s0149-7634(88)80061-7
Item in Clipboard
Review
A role for biogenic amines in developmental language disorders
Neurosci Biobehav Rev.
1988 Fall-Winter.
Abstract
The authors discuss the current uncertainty regarding etiology, treatment, and classification of developmental language disorders (DLD). Referring to previous reports in the literature, they propose a specific subclass of DLD associated with a hypothesized dysfunction of the dopaminergic system of the basal ganglia. Mechanisms of dysfunction and treatment implications are discussed.
Similar articles
-
A treatable language disorder: pharmacological treatment of pervasive developmental disorder.J Dev Behav Pediatr. 1986 Apr;7(2):73-6. doi: 10.1097/00004703-198604000-00001. J Dev Behav Pediatr. 1986. PMID: 3700663
-
Drugs affecting monoamines in the basal ganglia.Adv Biochem Psychopharmacol. 1972;6:135-48. Adv Biochem Psychopharmacol. 1972. PMID: 4560163 Review. No abstract available.
-
[Huntington's disease: molecular foundations and implications in the characterisation of the neuronal mechanisms responsible for linguistic processing].Rev Neurol. 2009 Jan 16-31;48(2):75-84. Rev Neurol. 2009. PMID: 19173205 Review. Spanish.
-
Role of biogenic amines in the central nervous system.Psychopharmacol Bull. 1975 Jul;11(3):61. Psychopharmacol Bull. 1975. PMID: 807931 No abstract available.
-
Recent developments in Parkinson's disease and Huntington's chorea.Int J Neurol. 1976;11(1):17-27. Int J Neurol. 1976. PMID: 138661 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous